X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 19th April, 2019 on account of Good Friday.

GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1%
Mon, 18 Feb

GSK CONSUMER has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

GSK CONSUMER Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m10,34712,72011,168-12.2%7.9%
Other incomeRs m6428901,24339.6%93.6%
TurnoverRs m10,98913,61012,411-8.8%12.9%
ExpensesRs m8,3079,1838,783-4.4%5.7%
Gross profitRs m2,0403,5372,385-32.6%16.9%
DepreciationRs m1511511584.9%4.4%
InterestRs m22210.5%23.5%
Profit before taxRs m2,5294,2743,468-18.9%37.1%
TaxRs m8921,5191,257-17.3%40.9%
Profit after taxRs m1,6372,7552,211-19.8%35.1%
Gross profit margin%19.727.821.4
Effective tax rate%35.335.536.2
Net profit margin%14.920.217.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 7.9% on a year-on-year (YoY) basis. The expenses were up by 5.7% YoY during the same period.
  • The company's operating profit increased by 16.9% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 21.4% in 3QFY19 as against 19.7% in 3QFY18.
  • Depreciation charges increased by 4.4% and finance costs increased by 23.5% YoY, respectively.
  • Other income increased by 93.6% YoY during the quarter.
  • Net profit for the quarter increased by 35.1% YoY. Net profit margins during the quarter increased from 14.9% in 3QFY18 to 17.8% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 12.2% on a quarter-on-quarter (QoQ) basis. The expenses were down by 4.4% QoQ during the same period.
  • The company's operating profit declined by 32.6% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 21.4% in 3QFY19 as against 27.8% in 2QFY18.
  • Net profit for the quarter declined by 19.8% QoQ, while net profit margins declined from 20.2% in 2QFY18 to 17.8% in 3QFY19.

To see how GSK CONSUMER has performed over the last eight quarters, please visit here.

GSK CONSUMER Share Price Performance

Over the last one year, GSK CONSUMER share price has moved up from Rs 6,478.5 to Rs 7,296.4, registering a Gain of Rs 817.9 or around 12.6%.

Overall, the S&P BSE SENSEX is up 3.6% over the year.

Current Valuations

At the current price of Rs 7,296.4, the price to earnings (P/E) ratio of GSK CONSUMER stands at 33.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 8.8 times.

Equitymaster requests your view! Post a comment on "GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1%". Click here!

  

Related Views on News

GSK CONSUMER Announces Quarterly Results (2QFY19); Net Profit Up 43.2% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GSK CONSUMER has posted a net profit of Rs 3 bn (up 43.2% YoY). Sales on the other hand came in at Rs 13 bn (up 14.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

Prataap Snacks Ltd. (IPO)

Sep 21, 2017

Is the Prataap Snacks IPO worth your attention?

Apex frozen food Ltd. (IPO)

Aug 21, 2017

Should you subscribe to the IPO of Apex Frozen Foods Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 18, 2019 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS